Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.2M Hold
667
0.72% 11
2022
Q3
$3.4M Hold
667
1.16% 9
2022
Q2
$2.42M Hold
667
0.77% 13
2022
Q1
$3.28M Hold
667
0.93% 13
2021
Q4
$7.93M Hold
667
1.92% 12
2021
Q3
$8.57M Hold
667
1.94% 13
2021
Q2
$9.2M Hold
667
2.84% 12
2021
Q1
$16.6M Hold
667
5.72% 7
2020
Q4
$15M Hold
667
5.12% 6
2020
Q3
$17.2M Buy
+667
New +$18.1M 3.69% 6

Other funds holding NCNA

Abingworth's NCNA Position: Q4 2022 in Review

Abingworth held its NuCana (NCNA) position steady in Q4 2022 at 667 shares worth $2.2M. The position accounts for 0.72% of the portfolio, ranked #11.

Abingworth first reported a position in NCNA in Q3 2020 and has held it in 10 quarters since. The position peaked at $17.2M in Q3 2020. 22 funds tracked by Wall St. Rank hold NCNA as of Q4 2022.

  • Abingworth held 667 shares of NuCana worth $2.2M as of Q4 2022.
  • Abingworth left its NuCana share count unchanged in Q4 2022.
  • NuCana made up 0.72% of Abingworth's portfolio in Q4 2022, its #11 holding.
  • Abingworth first reported a position in NuCana in Q3 2020 and has held it in 10 quarters since.
  • Abingworth's NuCana position peaked at $17.2M in Q3 2020.
  • 22 funds tracked by Wall St. Rank held NuCana as of Q4 2022.

Based on Abingworth's 13F filing for Q4 2022, filed 10 Feb 2023.